TELA Bio, Inc. (NASDAQ: TELA) reported Q2 EPS of ($0.20), $0.03 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $19.3 million versus the consensus estimate of $21.04 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.